Patentscope RSS feed

PERINDOPRIL TOSYLATE (Wed, 28 Sep 2011)
The present invention relates to a novel salt of perindopril, namely the paratoluene sulfonic acid salt. The present invention also relates to an amorphous form of the perindopril paratoluene sulfonic acid salt. The invention further relates to processes for the preparation of the novel salt and the amorphous form thereof. The invention also relates to pharmaceutical compositions comprising the perindopril tosylate for the treatment of hypertension and heart failure.
>> Read More

CRYSTALLINE FORMS OF FEBUXOSTAT (Wed, 28 Dec 2011)
New forms of Febuxostat have been prepared and characterized. These forms are useful, for example, in the chronic management of hyperuricemia in patients with gout.
>> Read More

Crystalline form of tigecycline and processes for preparation thereof (Wed, 17 Nov 2010)
The present invention provides a crystalline form of Tigecycline, and methods of for preparation of said crystalline form.
>> Read More

Crystalline forms of febuxostat (Wed, 12 Dec 2012)
New forms of Febuxostat have been prepared and characterized. These forms are useful, for example, in the chronic management of hyperuricemia in patients with gout.
>> Read More

Crystalline form of tigecycline and processes for preparation thereof (Wed, 06 Oct 2010)
The present invention provides a crystalline form of Tigecycline, and methods of for preparation of said crystalline form.
>> Read More

Crystal form of 9-hydroxy-risperidone (paliperidone) (Wed, 16 Dec 2009)
The present invention provides a crystalline form of Paliperidone, and processes for preparing thereof.
>> Read More

SOLID STATE FORMS OF PEMAFIBRATE (Thu, 04 Jul 2019)
The present disclosure relates to solid state forms of Pemafibrate processes for preparation thereof and pharmaceutical compositions thereof.
>> Read More

Crystalline forms of febuxostat (Thu, 19 Sep 2013)
New forms of Febuxostat have bean, prepared and characterized. These forms are useful for examples in the chronic management of hyperuricemia in patients with gout.
>> Read More

Crystalline forms of Febuxostat (Thu, 11 Jul 2013)
New forms of Febuxostat have been prepared and characterized. These forms are useful, for example, in the chronic management of hyperuricemia in patients with gout.
>> Read More

SOLID STATE FORMS OF SITAGLIPTIN SALTS (Thu, 14 Oct 2010)
Solid state forms of Sitagliptin salts, processes for preparing the solid state forms, and pharmaceutical composi-tions thereof, are provided.
>> Read More

Crystal form of 9-hydroxy-risperidone (paliperidone) (Wed, 16 Dec 2009)
The present invention provides a crystalline form of Paliperidone, and processes for preparing thereof.
>> Read More

Raltegravir salts and crystalline forms thereof (Thu, 18 Apr 2013)
The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium.
>> Read More

RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF (Wed, 16 Jan 2013)
The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium.
>> Read More

NILOTINIB HCI CRYSTALLINE FORMS (Wed, 22 Dec 2010)
Crystalline forms of Nilotinib HCl are described. (I)
>> Read More

Crystalline raltegravir sodium salts (Wed, 29 Oct 2014)
The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium.
>> Read More

A SOLID STATE FORM OF PERAMPANEL (Thu, 27 Oct 2016)
The present disclosure relates to solid state forms of Perampanel, processes for preparation thereof and pharmaceutical compositions thereof.
>> Read More

CRYSTALLINE SIPONIMOD FUMARIC ACID AND POLYMORPHS THEREOF (Thu, 25 Jul 2019)
Disclosed crystalline Siponimod fumaric acid, solid state forms (polymorphs) thereof, processes for preparation thereof and pharmaceutical compositions thereof.
>> Read More

CRYSTALLINE FORMS OF FEBUXOSTAT (Thu, 16 Dec 2010)
New forms of Febuxostat have been prepared and characterized. These forms are useful, for example, in the chronic management of hyperuricemia in patients with gout.
>> Read More

SOLID STATE FORMS OF CABAZITAXEL AND PROCESSES FOR PREPARATION THEREOF (Wed, 29 Jan 2014)
The invention relates to solid state forms of Cabazitaxel, and processes for preparation, via novel synthetic intermediates, thereof, and formulations comprising one or more of the solid state forms of Cabazitaxel. The present invention further provides pharmaceutical compositions comprising one or more of the solid state forms of Cabazitaxel, and a method of treating hormone-refractory prostate cancer.
>> Read More

Solid state forms of sitagliptin salts (Thu, 06 Oct 2011)
Crystalline forms of Sitagliptin salts, processes for preparing crystalline forms of Sitagliptin salts, and pharmaceutical compositions of Sitagliptin salts are provided.
>> Read More